Oarsman Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Sell
4,452
-145
-3% -$43.2K 0.15% 83
2025
Q4
$1.52M Buy
4,597
+105
+2% +$35.6K 0.2% 82
2025
Q3
$1.55M Sell
4,492
-312
-6% -$94.4K 0.22% 77
2025
Q2
$1.5M Sell
4,804
-163
-3% -$62.3K 0.24% 83
2025
Q1
$2.6M Buy
4,967
+224
+5% +$115K 0.47% 41
2024
Q4
$2.4M Buy
4,743
+649
+16% +$369K 0.42% 45
2024
Q3
$2.39M Buy
4,094
+173
+4% +$97.8K 0.44% 46
2024
Q2
$2M Buy
3,921
+194
+5% +$95.1K 0.44% 48
2024
Q1
$1.84M Sell
3,727
-492
-12% -$250K 0.44% 50
2023
Q4
$2.22M Buy
4,219
+138
+3% +$73.6K 0.59% 42
2023
Q3
$2.06M Buy
4,081
+26
+0.6% +$12.8K 0.86% 26
2023
Q2
$1.95M Sell
4,055
-559
-12% -$273K 0.85% 27
2023
Q1
$2.18M Sell
4,614
-1
-0% -$483 1.02% 23
2022
Q4
$2.45M Sell
4,615
-472
-9% -$250K 1.25% 16
2022
Q3
$2.57M Sell
5,087
-223
-4% -$117K 1.38% 16
2022
Q2
$2.73M Buy
5,310
+76
+1% +$38.2K 1.35% 19
2022
Q1
$2.67M Sell
5,234
-294
-5% -$142K 1.04% 25
2021
Q4
$2.78M Sell
5,528
-27
-0.5% -$12.2K 1.09% 23
2021
Q3
$2.17M Buy
5,555
+7
+0.1% +$2.9K 0.88% 31
2021
Q2
$2.22M Sell
5,548
-401
-7% -$160K 0.88% 29
2021
Q1
$2.21M Sell
5,949
-1,374
-19% -$476K 0.96% 22
2020
Q4
$2.57M Buy
7,323
+25
+0.3% +$8.38K 1% 26
2020
Q3
$2.27M Sell
7,298
-421
-5% -$129K 1.03% 28
2020
Q2
$2.28M Buy
7,719
+1,084
+16% +$311K 1.13% 25
2020
Q1
$1.66M Sell
6,635
-1,013
-13% -$279K 1.53% 21
2019
Q4
$2.25M Sell
7,648
-92
-1% -$24.1K 1.03% 27
2019
Q3
$1.68M Buy
7,740
+136
+2% +$32.8K 0.8% 44
2019
Q2
$1.85M Buy
7,604
+1,315
+21% +$316K 0.84% 43
2019
Q1
$1.55M Buy
6,289
+3,483
+124% +$888K 0.74% 49
2018
Q4
$699K Buy
2,806
+1
+0% +$264 0.36% 86
2018
Q3
$746K Sell
2,805
-555
-17% -$144K 0.3% 89
2018
Q2
$824K Sell
3,360
-300
-8% -$72K 0.37% 85
2018
Q1
$783K Sell
3,660
-189
-5% -$43.2K 0.36% 87
2017
Q4
$849K Sell
3,849
-100
-3% -$21.2K 0.37% 85
2017
Q3
$773K Sell
3,949
-129
-3% -$24.9K 0.33% 85
2017
Q2
$756K Sell
4,078
-150
-4% -$26.3K 0.35% 84
2017
Q1
$693K Sell
4,228
-1,220
-22% -$200K 0.32% 86
2016
Q4
$872K Sell
5,448
-1,945
-26% -$291K 0.56% 60
2016
Q3
$1.03M Hold
7,393
0.53% 66
2016
Q2
$1.04M Buy
7,393
+6
+0.1% +$800 0.54% 66
2016
Q1
$952K Sell
7,387
-39
-0.5% -$4.61K 0.51% 75
2015
Q4
$874K Buy
7,426
+619
+9% +$72.3K 0.49% 72
2015
Q3
$790K Buy
6,807
+60
+0.9% +$7.18K 0.47% 75
2015
Q2
$823K Buy
6,747
+295
+5% +$34.9K 0.56% 64
2015
Q1
$763K Buy
6,452
+46
+0.7% +$5.11K 0.53% 69
2014
Q4
$648K Buy
6,406
+1,050
+20% +$99.5K 0.47% 74
2014
Q3
$462K Buy
5,356
+311
+6% +$26.3K 0.34% 105
2014
Q2
$412K Buy
5,045
+475
+10% +$37.4K 0.3% 115
2014
Q1
$375K Buy
4,570
+820
+22% +$61.7K 0.29% 117
2013
Q4
$282K Buy
+3,750
New +$269K 0.23% 122

Other funds holding UNH

Oarsman Capital's UNH Position: Q1 2026 in Review

Oarsman Capital reduced its UnitedHealth (UNH) stake by 3.2% in Q1 2026, selling an estimated $43.2K and leaving 4,452 shares worth $1.2M. The position accounts for 0.15% of the portfolio, ranked #83.

Oarsman Capital first reported a position in UNH in Q4 2013 and has held it in 50 quarters since. The position peaked at $2.78M in Q4 2021. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Oarsman Capital held 4,452 shares of UnitedHealth worth $1.2M as of Q1 2026.
  • Oarsman Capital sold 145 UnitedHealth shares in Q1 2026, an estimated $43.2K.
  • UnitedHealth made up 0.15% of Oarsman Capital's portfolio in Q1 2026, its #83 holding.
  • Oarsman Capital first reported a position in UnitedHealth in Q4 2013 and has held it in 50 quarters since.
  • Oarsman Capital's UnitedHealth position peaked at $2.78M in Q4 2021.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Oarsman Capital's 13F filing for Q1 2026, filed 28 Apr 2026.